Literature DB >> 892345

Vasoactive intestinal peptide: a secretin-like partial agonist for pancreatic secretion in man.

S Domschke, W Domschke, W Rösch, S J Konturek, W Sprügel, P Mitznegg, E Wünsch, L Demling.   

Abstract

The responses of pancreatic volume flow and bicarbonate output to intravenous vasoactive intestinal peptide (VIP, 0.8 to 3.2 microgram per kg per hr) and synthetic secretin (32.2 to 129 ng per kg per hr) were compared intraindividually in 5 healthy volunteers. Pure pancreatic juice was obtained by endoscopic cannulation of the main pancreatic duct. The mean +/- SEM observed maximal response of secretin-stimulated juice flow was 248 +/- 7 microliter per kg per 5 min, whereas the observed maximal response for VIP-evoked juice flow was 48 +/- 6 microliter per kg per 5 min. The observed maximal secretin-induced bicarbonate output was 30 +/- 2 muEq per kg per 5 min, and the maximal VIP-related response was 4.3 +/- 0.9 muEq per kg per 5 min. In addition to low efficacy, high dose requirements, and side effects (significant rise in pulse rate and cutaneous flushing at 3.2 micrograms per kg per hr) argue against a major physiological role of VIP as a hormonal stimulant of human pancreatic bicarbonate secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892345

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Current concepts of neuro-hormonal control of pancreatic secretion.

Authors:  S J Konturek
Journal:  Ir J Med Sci       Date:  1978-01       Impact factor: 1.568

2.  Adenylate cyclase activity in human pancreatic adenocarcinoma cell lines.

Authors:  L al-Nakkash; N L Simmons; J M Lingard; B E Argent
Journal:  Int J Pancreatol       Date:  1996-02

3.  Peptide characterization of secretin preparations.

Authors:  M M Wolfe; J E Howard; B E Kolts; J E McGuigan
Journal:  Dig Dis Sci       Date:  1986-03       Impact factor: 3.199

4.  Vasoactive intestinal peptide (VIP) occurs in nerves of the pineal gland.

Authors:  R Uddman; J Alumets; R Häkanson; I Lorén; F Sundler
Journal:  Experientia       Date:  1980-09-15

5.  Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.

Authors:  S Domschke; W Domschke; S R Bloom; P Mitznegg; S J Mitchell; G Lux; U Strunz
Journal:  Gut       Date:  1978-11       Impact factor: 23.059

6.  Effect of intracerebroventricular injection of vasoactive intestinal polypeptide on systemic blood pressure and pancreatic and gastric secretions in the rat.

Authors:  K Mizuta; M Moriga; H Narusawa; H Uchino; M Aono
Journal:  Gastroenterol Jpn       Date:  1986-02

7.  Potent stimulation of the avian exocrine pancreas by porcine and chicken vasoactive intestinal peptide.

Authors:  R Dimaline; G J Dockray
Journal:  J Physiol       Date:  1979-09       Impact factor: 5.182

8.  Expression of receptors for gut peptides in human pancreatic adenocarcinoma and tumour-free pancreas.

Authors:  C Tang; I Biemond; G J Offerhaus; W Verspaget; C B Lamers
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.